Hong Guo

VP, Development at Inflammasome Therapeutics Inc


Dr. Guo has focused on sustained drug delivery technologies and products which can improve the quality of life for patients throughout her career. She has made significant contributions to the design and development of three FDA approved, sustained release, intravitreal implantable/injectable products. Dr. Guo brings over 25 years experience to the team, developing drug products from early feasibility to clinical development and commercialization. She has expertise in various CMC functions including formulation development, analytical development, ocular delivery, preclinical research and regulatory submission. A medicinal chemist by training, Dr. Guo is the inventor/co-inventor for numerous U.S and international patents and applications.


  • VP, Development

    Current role

View in org chart